News & Events

NUS Researchers Develop AI Platform to Rapidly Identify Optimal Personalised Drug Combinations for Myeloma Patients

Congratulations to Dr Edward Chow (2nd from the left) and Professor Dean Ho (1st from the right), from Department of Pharmacology, who are part of a multidisciplinary team of researchers from the National University of Singapore (NUS) who has developed an artificial intelligence (AI) technology platform that could potentially change the way drug combinations are being designed, hence enabling doctors to determine the most effective drug combination for a patient quickly.

Leave a Comment

Your email address will not be published. Required fields are marked *

Scroll to Top